These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 10983894)

  • 1. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?
    Simeonova PP; Luster MI
    J Environ Pathol Toxicol Oncol; 2000; 19(3):281-6. PubMed ID: 10983894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogen exposure and epigenetic silencing in bladder cancer.
    Marsit CJ; Karagas MR; Schned A; Kelsey KT
    Ann N Y Acad Sci; 2006 Sep; 1076():810-21. PubMed ID: 17119258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers.
    Waalkes MP; Ward JM; Diwan BA
    Carcinogenesis; 2004 Jan; 25(1):133-41. PubMed ID: 14514661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six primary cancers in one Lynch syndrome patient with chronic arsenic exposure.
    Chen PC; Chen WC; Chao SC; Lin BW; Lin SC; Chen CJ; Lee JC
    J Surg Oncol; 2012 Mar; 105(3):329-30. PubMed ID: 21882197
    [No Abstract]   [Full Text] [Related]  

  • 5. Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
    Marsit CJ; Karagas MR; Danaee H; Liu M; Andrew A; Schned A; Nelson HH; Kelsey KT
    Carcinogenesis; 2006 Jan; 27(1):112-6. PubMed ID: 15987713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding arsenic carcinogenicity by the use of animal models.
    Wanibuchi H; Salim EI; Kinoshita A; Shen J; Wei M; Morimura K; Yoshida K; Kuroda K; Endo G; Fukushima S
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):366-76. PubMed ID: 15276416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemical-induced cancers].
    Bergeret A; Normand JC
    Rev Prat; 2000 Feb; 50(4):391-5. PubMed ID: 10748670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic carcinogenicity: relevance of c-Src activation.
    Simeonova PP; Luster MI
    Mol Cell Biochem; 2002; 234-235(1-2):277-82. PubMed ID: 12162444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.
    Kitchin KT
    Toxicol Appl Pharmacol; 2001 May; 172(3):249-61. PubMed ID: 11312654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicological principles of metal carcinogenesis with special emphasis on cadmium.
    Waalkes MP; Coogan TP; Barter RA
    Crit Rev Toxicol; 1992; 22(3-4):175-201. PubMed ID: 1388705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The cancerous action of arsenic and nickel (author's transl)].
    Konetzke GW
    Arch Geschwulstforsch; 1974; 44(1):16-22. PubMed ID: 4447437
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis.
    Mink PJ; Alexander DD; Barraj LM; Kelsh MA; Tsuji JS
    Regul Toxicol Pharmacol; 2008 Dec; 52(3):299-310. PubMed ID: 18783726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human PBPK/PD model to assess arsenic exposure risk through farmed tilapia consumption.
    Ling MP; Liao CM
    Bull Environ Contam Toxicol; 2009 Jul; 83(1):108-14. PubMed ID: 19452117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of action for metallic elements and their species classified carcinogen R 45 and R 49 by EU].
    Apostoli P; Catalani S
    G Ital Med Lav Ergon; 2008; 30(4):382-91. PubMed ID: 19344091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is cadmium a human carcinogen?
    Kazantzis G; Blanks RG; Sullivan KR
    IARC Sci Publ; 1992; (118):435-46. PubMed ID: 1303971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice.
    Waalkes MP; Liu J; Ward JM; Diwan BA
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):377-84. PubMed ID: 15276417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in industrial carcinogens.
    Eckardt RE
    J Occup Med; 1973 Nov; 15(11):904-7. PubMed ID: 4584933
    [No Abstract]   [Full Text] [Related]  

  • 18. Trace metals and neoplasia.
    Sky-Peck HH
    Clin Physiol Biochem; 1986; 4(1):99-111. PubMed ID: 3514058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.
    Clewell HJ; Thomas RS; Gentry PR; Crump KS; Kenyon EM; El-Masri HA; Yager JW
    Toxicol Appl Pharmacol; 2007 Aug; 222(3):388-98. PubMed ID: 17499324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal ions in human cancer development.
    Tokar EJ; Benbrahim-Tallaa L; Waalkes MP
    Met Ions Life Sci; 2011; 8():375-401. PubMed ID: 21473387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.